Related Experiment Video
Updated: Mar 16, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Lymphocytic Interstitial Pneumonia
Tanmay S Panchabhai1, Carol Farver2, Kristin B Highland3
1Department of Medicine, Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Creighton University School of Medicine, Phoenix Regional Campus, 500 West Thomas Road, Suite 500, Phoenix, AZ 85013, USA.
Lymphocytic interstitial pneumonia (LIP) is a rare lung disorder. Diagnosing underlying conditions and differentiating LIP from lymphoma using immunohistochemistry is crucial for patient outcomes.
Area of Science:
- Pulmonology
- Pathology
- Radiology
Background:
- Lymphocytic interstitial pneumonia (LIP) is a rare benign pulmonary lymphoproliferative disorder.
- LIP often co-occurs with connective tissue diseases or infections.
- Idiopathic LIP is uncommon, necessitating thorough investigation for underlying causes.
Purpose of the Study:
- To highlight the diagnostic challenges and key features of Lymphocytic interstitial pneumonia.
- To emphasize the importance of identifying associated conditions and differentiating LIP from lymphoma.
- To provide an overview of imaging findings and prognostic factors in LIP.
Main Methods:
- Review of clinical, radiological, and pathological findings in patients with LIP.
- Computed tomography (CT) scan analysis for characteristic lung opacities and cysts.
- Immunohistochemistry to assess the clonality of lymphoid infiltrates.
Main Results:
- CT scans may show ground-glass opacities, nodules, and cysts.
- Immunohistochemistry demonstrating polyclonality is key to distinguishing LIP from lymphoma.
- Associated conditions significantly influence the disease course and prognosis.
Conclusions:
- Accurate diagnosis of LIP requires a multidisciplinary approach, integrating clinical, imaging, and pathological data.
- Identifying and managing underlying conditions are critical for improving the prognosis of LIP.
- The 5-year mortality for LIP ranges from 33% to 50%, underscoring the disease's severity.
More Related Videos
06:15Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: